ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
Implementing an Evidence-Based Guideline to Improve Perioperative Antimicrobial Prophylaxis Quality Among Patients With Penicillin Allergy Labels.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To implement a quality improvement project to promote cefazolin for surgical antimicrobial prophylaxis (SAP) among patients with penicillin allergy labels (PwPAL) as updated guidelines suggest shifting SAP to preferred antibiotics (cefazolin) in PwPAL, including penicillin-associated anaphylaxis. Patients and Methods: An interdisciplinary quality improvement project was conducted in a large, multiregion health care system in the United States to promote cefazolin for SAP among PwPAL. Interventions occurred January 1, 2023 through November 30, 2023 and were applied to adult and pediatric PwPAL undergoing operation. Broad system-based changes were implemented, including electronic health record allergy module enhancements, algorithm development, and point-of-care guidance to surgical clinicians through modifications to the electronic health record allergy-antibiotic flag at order entry and to surgical order sets. A dashboard was created to capture all SAP data, and education modules and communication articles were disseminated. Practice representative input was obtained, and frequent updates were provided through departmental meetings. Results: Use of cefazolin for SAP in PwPAL improved 38% across all regions within our health care organization, increasing from 63.4% (8349/13,164) to 89.1% (12,988/14,569), Conclusion: A successful increase in the use of cefazolin for SAP in PwPAL was achieved through broad quality improvement project implementation of system-based interventions without a corresponding increase in hypersensitivity surrogate markers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.